Health care policy issues as a result of the genetic revolution: Implications for public health

American Journal of Public Health

Volumn 95, Issue 3, 2005, Pages 385-388

  Ojha, Rohit P ^a,b   Thertulien, Raymond ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b Myeloma Inst for Res and Therapy ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA SEQUENCE; GENETIC ANALYSIS; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HUMAN; MEDICAL RECORD; PATENT; PRACTICE GUIDELINE; PRIVACY; PUBLIC HEALTH; REVIEW; SOCIETY; STANDARDIZATION;

BIOMEDICAL AND BEHAVIORAL RESEARCH; GENETICS AND REPRODUCTION;

BASE SEQUENCE; GENETIC PRIVACY; GENETIC RESEARCH; GENETIC TECHNIQUES; GENETICS, MEDICAL; GUIDELINES; HEALTH EDUCATION; HEALTH OCCUPATIONS; HEALTH POLICY; HUMAN GENOME PROJECT; HUMANS; NEEDS ASSESSMENT; ORGANIZATIONAL INNOVATION; PATENTS; POLICY MAKING; PUBLIC HEALTH; SOCIAL CONTROL, FORMAL; UNITED STATES;

EID: 14644404341     PISSN: 00900036     EISSN: None     Source Type: Journal    
DOI: 10.2105/AJPH.2003.026708     Document Type: Review

References (27)

1. Austin MJ, Kreiner T. Integrating genomic technologies in health care: practice and policy challenges and opportunities. Physiol Genomics. 2002;8: 33-40.
2. Collins F, McKusick V. Implications of the Human Genome Project for medical science. JAMA. 2001;285: 540-544.
3. Austin MA, Peyser P, Khoury M. The interface of genetics and public health: research and educational challenges. Annu Rev Public Health. 2000; 21:81-99.
4. Omenn G. Public health genetics: an emerging interdisciplinary field for the post-genomic era. Ann Rev Public Health. 2001;21:1-13.
5. Little J, Bradley L, Bray M, et al. Reporting, appraising, and integrating data on genotype prevalence and gene-disease associations. Am J Epidemiol. 2002;156:300-310.
6. Collins F. Shattuck lecture-medical and societal consequences of the human genome project. N Engl J Med. 1999; 341:28-37.
7. Pang T. The impact of genomics on global health. Am J Pub Health. 2002; 92:1077-1079.
8. Perera F. Molecular epidemiology: on the path to prevention? J Natl Cancer Inst. 2000;92:602-612.
9. Khoury MJ, Beskow L, Gwinn ML. Translation of genomic research into health care. JAMA. 2001;285: 2447-2448.
10. Burns J, Cook-Degan R, Alberts B. The Human Genome Project after a decade: policy issues. Nat Genet. 1998; 20:333-335.
11. Shinaman A, Bain LI, Shoulson I. Preempting genetic discrimination and assaults on privacy: report of a symposium. Am J Med Genet. 2003;4: 589-593.
12. US Department of Energy. Human Genome Project Progress. 2004. Available at: http://www.ornl.gov/sci/techresources/Human_Genome/project/progress.shtml. Accessed January 4, 2004.
13. Fuller BP, Kahn MJ, Ellis MJ, et al. Privacy in genetics research. Science. 1999;285:1359-1361.
14. Private matters, public affairs. Nat Genet. 2000;26:1-2.
15. Burke W, Atkins D, Gwinn M, et al. Genetic test evaluation: information needs of clinicians, policy makers, and the public. Am J Epidemiol. 2002;156: 311-318.
16. Caulfield TA, Gold ER. Genetic testing, ethical concerns, and the role of patent law. Clin Genet. 2000;57: 370-375.
17. Thomas SM, Hopkins MM, Brady M. Shares in the human genome-the future of patenting DNA. Nat Biotechnol. 2002;12:1185-1188.
18. Caulfield TA, Knoppers BM, Gold ER, Sheremeta LE, Bridge PJ. Genetic technologies, health care policy, and the patent bargain. Clin Genet. 2003;63: 15-18.
19. Bobrow M, Thomas S. Patents in a genetic age. Nature. 2000;409: 763-764.
20. Centers for Medicare and Medicaid Services. The Health Insurance Portability and Accountability Act of 1996 (HIPAA). 2002. Available at http://cms.hhs.gov/hipaa. Accessed January 3, 2004.
21. Piper M, Lindenmayer JM, Lengerich EJ, et al. The role of state public health agencies in genetics and disease prevention: results of a national survey. Public Health Rep. 2001;116: 22-31.
22. Gold T, Caulfield TA, Ray P. Gene patents and the standard of care. CMAJ. 2002;167:256-257.
23. Ilag LL, Ilag LM, Ilag LL. From patenting genes to proteins: the search for utility via function. Trends Biotechnol. 2002;5:197-199.
24. Willison D, MacLeod S. Patenting of genetic material: are the benefits to society being realized? CMAJ. 2002; 167:259-262.
25. Gostin, L. Public health law in a new century: part I: law as a tool to advance the community's health. JAMA. 2000;283:2837-2841.
26. Guttmacher AE, Collins, PS. Welcome to the genomic era. N Engl J Med. 2003;349:996-998.
27. Giardello F, Brensinger JD, Petersen GM, et al. The use and interpretation of commercial ape gene testing for familial adenomatous polyposis. N Engl J Med. 1997;336:823-827.